Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Disulfiram|DRUG: Vinorelbin|DRUG: Cisplatin|DRUG: Copper
Sponsor: National Cancer Institute, Slovakia